MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,799,926 | -26.9% | 1,628,377 | +4.6% | 0.00% | – |
| Q2 2023 | $10,663,998 | -5.4% | 1,556,788 | +7.6% | 0.00% | – |
| Q1 2023 | $11,275,510 | +3.9% | 1,447,434 | +1.5% | 0.00% | – |
| Q4 2022 | $10,857,294 | -5.6% | 1,426,714 | +1.4% | 0.00% | – |
| Q3 2022 | $11,501,000 | -47.4% | 1,407,667 | -37.8% | 0.00% | -100.0% |
| Q2 2022 | $21,882,000 | -48.0% | 2,262,906 | -24.6% | 0.00% | 0.0% |
| Q1 2022 | $42,098,000 | +90.8% | 3,002,772 | +177.9% | 0.00% | 0.0% |
| Q4 2021 | $22,066,000 | -2.9% | 1,080,616 | +5.9% | 0.00% | 0.0% |
| Q3 2021 | $22,726,000 | +901.1% | 1,020,021 | +920.0% | 0.00% | – |
| Q2 2021 | $2,270,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $7,052,465 | 2.91% |
| NEA Management Company, LLC | 7,692,298 | $36,846,107 | 2.85% |
| Octagon Capital Advisors LP | 812,895 | $3,893,767 | 0.60% |
| Alphabet Inc. | 1,464,015 | $7,012,631 | 0.45% |
| Avoro Capital Advisors LLC | 4,535,000 | $21,722,650 | 0.34% |
| Casdin Capital, LLC | 510,882 | $2,447,125 | 0.27% |
| Baker Brothers Advisors | 4,916,095 | $23,548,095 | 0.14% |
| Corton Capital Inc. | 14,460 | $69,263 | 0.04% |
| ExodusPoint Capital Management, LP | 619,248 | $2,966 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 27,844 | $133,373 | 0.02% |